select a format

Single User License
USD 250 INR 16360
Site License
USD 500 INR 32720
Corporate User License
USD 750 INR 49080

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Sunshine Biopharma Inc (SBFM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Sunshine Biopharma Inc (SBFM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH195110D
  • |
  • Pages: 38
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that provides research, development and commercialization of drugs for treating cancer disease. The company's drug candidate is Adva-27a, a small molecule against different types of multidrug resistant cancer cell lines. It also provides difluoro-etoposide, which is a multipurpose anti-tumor compound. The company offers products for breast cancer, uterine carcinoma, pancreatic cancer and small-cell lung cancer, kidney cancer, and squamous-cell carcinomas. Sunshine BioPharma is headquartered in Montreal, Quebec, Canada.

Sunshine Biopharma Inc (SBFM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Sunshine Biopharma Acquires Remaining Patent Rights for Adva-27a from Advanomics 12

Sunshine BioPharma Acquires Adva-27a Patents From Institut National des Sciences Appliquees 12

Venture Financing 13

Actinium Pharma Raises US$5 Million In First Closing Of Venture Financing Round 13

Actinium Pharma Secures US$4.1 Million In Initial Closing Of Series E Financing Round 14

Partnerships 15

Actinium Pharma Partners with Vector Oncology 15

Actinium Pharma Enters into Agreement with Medpace 16

Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 16

Sunshine Biopharma Enters Into Co-Development Agreement With Jewish General Hospital 17

Sunshine Biopharma Enters Into Collaboration With The Research Foundation Of The State University of New York 18

Licensing Agreements 19

Sunshine Biopharma Enters into Licensing Agreement 19

Sunshine Biopharma Enters into Licensing Agreement for Anastrozole 20

Actinium Pharma Enters Into Licensing Agreement With Fred Hutchinson Cancer Research Center For BC8 21

Equity Offering 22

Actinium Pharma Raises USD10 Million in Public Offering of Shares 22

Actinium Pharma Raises USD5 Million in Private Placement of Shares 23

Actinium Pharma Raises USD20 Million in Public Offering of Shares and warrants 25

Actinium Pharma Raises USD13.7 Million in Public Offering of Shares 26

Sunshine Biopharma to Raise up to USD2.5 Million in Private Placement of Shares 28

Actinium Pharma Completes Second Tranche Of Private Placement Of Securities For US$3.3 Million 29

Actinium Pharma Completes Private Placement Of Shares For US$3.5 Million Upon Exercise Of Warrants 30

Actinium Pharma Plans IPO 30

Sunshine Biopharma Completes Private Placement Of Shares For US$0.2 Million 31

Acquisition 32

Cactus Ventures Completes Acquisition Of Actinium Pharma In Reverse Takeover Transaction 32

Sunshine Biopharma Inc-Key Competitors 34

Key Employees 35

Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Product News 37

01/20/2016: Sunshine Biopharma Is Moving Forward With Its Development Plans for Adva-27a Anticancer Compound 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

List of Tables

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Sunshine Biopharma Inc, Deals By Therapy Area, 2011 to YTD 2017 9

Sunshine Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sunshine Biopharma Acquires Remaining Patent Rights for Adva-27a from Advanomics 12

Sunshine BioPharma Acquires Adva-27a Patents From Institut National des Sciences Appliquees 12

Actinium Pharma Raises US$5 Million In First Closing Of Venture Financing Round 13

Actinium Pharma Secures US$4.1 Million In Initial Closing Of Series E Financing Round 14

Actinium Pharma Partners with Vector Oncology 15

Actinium Pharma Enters into Agreement with Medpace 16

Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 16

Sunshine Biopharma Enters Into Co-Development Agreement With Jewish General Hospital 17

Sunshine Biopharma Enters Into Collaboration With The Research Foundation Of The State University of New York 18

Sunshine Biopharma Enters into Licensing Agreement 19

Sunshine Biopharma Enters into Licensing Agreement for Anastrozole 20

Actinium Pharma Enters Into Licensing Agreement With Fred Hutchinson Cancer Research Center For BC8 21

Actinium Pharma Raises USD10 Million in Public Offering of Shares 22

Actinium Pharma Raises USD5 Million in Private Placement of Shares 23

Actinium Pharma Raises USD20 Million in Public Offering of Shares and warrants 25

Actinium Pharma Raises USD13.7 Million in Public Offering of Shares 26

Sunshine Biopharma to Raise up to USD2.5 Million in Private Placement of Shares 28

Actinium Pharma Completes Second Tranche Of Private Placement Of Securities For US$3.3 Million 29

Actinium Pharma Completes Private Placement Of Shares For US$3.5 Million Upon Exercise Of Warrants 30

Actinium Pharma Plans IPO 30

Sunshine Biopharma Completes Private Placement Of Shares For US$0.2 Million 31

Cactus Ventures Completes Acquisition Of Actinium Pharma In Reverse Takeover Transaction 32

Sunshine Biopharma Inc, Key Competitors 34

Sunshine Biopharma Inc, Key Employees 35

Sunshine Biopharma Inc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sunshine Biopharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com